bpc-157 rapid - 250mcg Release InfiniWell | Herb Stop BPC-157 Peptide: Enhance Healing and

International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription

1 September

Food and Drug Administration (2023)

Epub 2019 Mar 27

Molecular Class: Synthetic peptide research material Net Content: 10 mg Purity: Research-grade, high-purity peptide Material State: Lyophilized powder Intended Use: Laboratory research only Research Applications In published scientific and preclinical literature, Cagrilintide 10mg is described as a synthetic peptide research material examined within controlled experimental systems under non-clinical laboratory conditions